These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23968824)
1. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents. Sharma R; Rawal RK; Gaba T; Singla N; Malhotra M; Matharoo S; Bhardwaj TR Bioorg Med Chem Lett; 2013 Oct; 23(19):5332-8. PubMed ID: 23968824 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery. Kumar S; Sharma B; Bhardwaj TR; Singh RK Anticancer Agents Med Chem; 2021; 21(3):383-392. PubMed ID: 32781967 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene-anticancer drug conjugates. Sharma R; Rawal RK; Malhotra M; Sharma AK; Bhardwaj TR Bioorg Med Chem; 2014 Feb; 22(3):1104-14. PubMed ID: 24405812 [TBL] [Abstract][Full Text] [Related]
4. Using Theory To Extend the Scope of Azobenzene Drugs in Chemotherapy: Novel Combinations for a Specific Delivery. Cerón-Carrasco JP; Jacquemin D ChemMedChem; 2021 Jun; 16(11):1764-1774. PubMed ID: 33619857 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel nucleoside analogue phosphorothioamidate prodrugs and in vitro anticancer evaluation against RKO human colon carcinoma cells. Liu W; Zhang L; Zhou H; Yang C; Miao Z; Zhao Y Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):161-73. PubMed ID: 24001190 [TBL] [Abstract][Full Text] [Related]
6. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB. Kim W; Nam J; Lee S; Jeong S; Jung Y Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518 [TBL] [Abstract][Full Text] [Related]
7. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats. Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512 [TBL] [Abstract][Full Text] [Related]
8. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209 [TBL] [Abstract][Full Text] [Related]
9. Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach. Suneela D; Gaurav V; Himanshu R Inflamm Allergy Drug Targets; 2013 Oct; 12(5):328-40. PubMed ID: 24001333 [TBL] [Abstract][Full Text] [Related]
10. Metronidazole prodrugs: synthesis, physicochemical properties, stability, and ex vivo release studies. Mura C; Valenti D; Floris C; Sanna R; De Luca MA; Fadda AM; Loy G Eur J Med Chem; 2011 Sep; 46(9):4142-50. PubMed ID: 21726922 [TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical approaches to colon targeted drug delivery systems. Chourasia MK; Jain SK J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and bio-evaluation of xylan-5-fluorouracil-1-acetic acid conjugates as prodrugs for colon cancer treatment. Sauraj ; Kumar SU; Gopinath P; Negi YS Carbohydr Polym; 2017 Feb; 157():1442-1450. PubMed ID: 27987854 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933 [TBL] [Abstract][Full Text] [Related]
14. Azo reductase- activated colon- targeting prodrugs of aminosalicylates for inflammatory bowel disease: preparation, pharmacokinetic and pharmacodynamic profile. Suneela D; Gaurav V; Samuel S Inflamm Allergy Drug Targets; 2013 Dec; 12(6):419-32. PubMed ID: 24266686 [TBL] [Abstract][Full Text] [Related]
16. Structure requirements for anaerobe processing of azo compounds: implications for prodrug design. Gavin J; Ruiz JF; Kedziora K; Windle H; Kelleher DP; Gilmer JF Bioorg Med Chem Lett; 2012 Dec; 22(24):7647-52. PubMed ID: 23122822 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease. Dhaneshwar SS; Gairola N; Kandpal M; Bhatt L; Vadnerkar G; Kadam SS Bioorg Med Chem Lett; 2007 Apr; 17(7):1897-902. PubMed ID: 17280832 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of mutual azo prodrugs of anti-inflammatory agents and peptides facilitated by α-aminoisobutyric acid. Kennedy DA; Vembu N; Fronczek FR; Devocelle M J Org Chem; 2011 Dec; 76(23):9641-7. PubMed ID: 22026631 [TBL] [Abstract][Full Text] [Related]
19. On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid. Sousa T; Yadav V; Zann V; Borde A; Abrahamsson B; Basit AW J Pharm Sci; 2014 Oct; 103(10):3171-5. PubMed ID: 25091594 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 2',3'-didehydro-2',3'-dideoxyinosine phosphoramidate prodrugs and evaluation of their anticancer activity. Borek W; Lewandowska M; Kleczewska N; Ruszkowski P; Kacprzak K; Celewicz L Nucleosides Nucleotides Nucleic Acids; 2014; 33(8):507-18. PubMed ID: 25009986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]